JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263769

Human SNCA (Alpha-synuclein) knockout HEK-293T cell lysate

Be the first to review this product! 리뷰 제출

|

(0 출판물)

SNCA KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2 and Insertion of the selection cassette in exon2.
2 이미지
Western blot - Human SNCA (Alpha-synuclein) knockout HEK-293T cell lysate (AB263769)
  • WB

Lab

Western blot - Human SNCA (Alpha-synuclein) knockout HEK-293T cell lysate (AB263769)

Lane 1 : Wild-type HEK-293T cell lysate (20ug)
Lane 2 : SNCA knockout HEK-293T cell lysate (20ug)

Lanes 1- 2 : Merged signal (red and green). Green - ab138501 observed at 18 kDa. Red - loading control ab8245 observed at 37 kDa.

ab138501 Recombinant Anti-Alpha-synuclein antibody [MJFR1] was shown to specifically react with SNCA in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab255433 (knockout cell lysate ab263769) was used. Wild-type and SNCA knockout samples were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab138501 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4oC at 1 in 10000 and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

Lanes 1 - 2:

Western blot - Anti-Alpha-synuclein antibody [MJFR1] (<a href='/ko/products/primary-antibodies/alpha-synuclein-antibody-mjfr1-ab138501'>ab138501</a>) at 1/10000 dilution

Lanes 1 - 2:

Anti-Alpha-synuclein antibody [MJFR1] - BSA and Azide free (<a href='/ko/products/unavailable/alpha-synuclein-antibody-mjfr1-bsa-and-azide-free-ab156369'>ab156369</a>) at 1/10000 dilution

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

SNCA knockout HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human SNCA (Alpha-synuclein) knockout HEK-293T cell line (<a href='/ko/products/cell-lines/human-snca-alpha-synuclein-knockout-hek-293t-cell-line-ab255433'>ab255433</a>)

Predicted band size: 14 kDa

Observed band size: 18 kDa

false

Sanger Sequencing - Human SNCA (Alpha-synuclein) knockout HEK-293T cell lysate (AB263769)
  • Sanger seq

Unknown

Sanger Sequencing - Human SNCA (Alpha-synuclein) knockout HEK-293T cell lysate (AB263769)

Allele-1 : Insertion of the selection cassette in exon2; Allele-2 : 1 bp insertion in exon2

주요 정보

세포 유형

HEK-293T

Species or organism

Human

조직

Kidney

Knockout 검증

Sanger Sequencing,Western blot

Mutation 정보

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2 and Insertion of the selection cassette in exon2.

style
left-column

보완 제품

Assay Kits

AB105136

Myeloperoxidase (MPO) Activity Assay Kit (Colorimetric)

Functional Studies - Myeloperoxidase (MPO) Activity Assay Kit (Colorimetric) (AB105136)

  • 4
  • 3
Assay Kits

AB235692

Cell Migration/Chemotaxis Assay Kit (96-well, 3 µm)

Functional Studies - Cell Migration/Chemotaxis Assay Kit (96-well, 3 µm) (AB235692)

  • 0
  • 0
Primary Antibodies

AB283256

Alexa Fluor® 488 Anti-KIR3DL1 antibody [EPR24357-139]

RabMAb|Recombinant

Immunocytochemistry/ Immunofluorescence - Alexa Fluor® 488 Anti-KIR3DL1 antibody [EPR24357-139] (AB283256)

  • 0
  • 0
Assay Kits

AB219929

Hypochlorite Assay Kit (Colorimetric)

Functional Studies - Hypochlorite Assay Kit (Colorimetric) (AB219929)

  • 0
  • 0
style
left-column

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }
style
left-column

제품 세부 정보

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

style
left-column

제품 구성

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263769-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB263769-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human SNCA knockout HEK293T cell lysate", "number":"AB263769-CMP01", "productcode":"" } ] } } }
style
left-column

특성 및 보관 정보

유전자명
SNCA
유전자 편집 종류
Knockout
유전자 편집 방식
CRISPR technology
Knockout 검증
Sanger Sequencing, Western blot
품질 관리 - STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
배송 시 보관 조건
Ambient - Can Ship with Ice
적절한 단기 보관 조건
-20°C
적절한 장기 보관 조건
-20°C
style
left-column

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

Alpha-synuclein often referred to by alternate names such as SNCA is a protein of around 14 kDa mass. It mainly expresses in the brain particularly in presynaptic nerve terminals. This protein functions mechanically by stabilizing synaptic vesicles and maintaining synaptic function. It exists both in soluble monomer forms and as aggregates in protein filaments. Antibodies like 4D6 and EP1536Y target monomer forms of protein for more detailed studies.
Biological function summary

The alpha-synuclein protein plays critical roles in neuronal activity. It contributes to neurotransmitter release regulation by acting in the formation and plasticity of the presynaptic neuronal network. Alpha-synuclein doesn't usually form parts of large protein complexes but it may associate transiently with membranes and vesicular structures. The protein's monomer form has also been observed in alpha lines and related neuronal processes operating alongside various cellular functions.

Pathways

Synaptic vesicle trafficking and dopamine neurotransmitter release are significant areas involving the alpha-synuclein protein. In these pathways alpha-synuclein interacts with other proteins like synaptophysin and protein monomer monomerizations are intrinsic to these processes. Altered function or aggregation of alpha-synuclein disrupts these pathways influencing broader neurological functions.

Alterations or accumulations of alpha-synuclein are strongly linked to Parkinson's disease and Lewy body dementia. In these conditions alpha-synuclein forms abnormal protein filaments known as Lewy bodies within neurons. These formations disrupt cellular processes and neuron health. Synucleinopathies such as these show connections with proteins like parkin and DJ-1 which also have key roles in these neurodegenerative diseases.
style
left-column

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

style
left-column

제품 프로토콜

style
left-column
style
left-column
style
right-column

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com